Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rexlemestrocel-L in chronic low back pain
NCT02412735Phase 3Completed
- Sponsor
- Mesoblast Ltd
- Start
- Mar 2015
- Primary completion
- May 2020
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of rexlemestrocel-l in degenerative disc disease (DDD), sponsored by Mesoblast Ltd. Started Mar 2015; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT02412735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412735.